THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY

<p>Up to date antithrombotic medications applied in patients with atrial fibrillation are discussed. Along with traditional drugs (acetylsalicylic acid, warfarin) rivaroxaban is specially considered<br />in terms of efficacy and safety of alone.</p>

書目詳細資料

主要作者:	M. Yu. Gilyarov
格式:	Artigo
語言:	Inglês
出版:	Столичная издательская компания 2015-12-01
叢編:	Рациональная фармакотерапия в кардиологии
主題:	фибрилляция предсердий антитромботическая терапия ривароксабан
在線閱讀:	http://www.rpcardio.ru/jour/article/view/504
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!